Chemoinformaics analysis of Dehydrodigallic acid
| Molecular Weight | 338.224 | nRot | 4 |
| Heavy Atom Molecular Weight | 328.144 | nRig | 16 |
| Exact Molecular Weight | 338.027 | nRing | 2 |
| Solubility: LogS | -3.907 | nHRing | 0 |
| Solubility: LogP | 7.784 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 12 |
| nHA | 8 | APOL | 38.0679 |
| nHD | 7 | BPOL | 13.5041 |
| QED | 0.085 |
| Synth | 4.719 |
| Natural Product Likeliness | 1.532 |
| NR-PPAR-gamma | 0.503 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.018 |
| Pgp-sub | 0.009 |
| HIA | 0.082 |
| CACO-2 | -5.126 |
| MDCK | 0.00000514 |
| BBB | 0.012 |
| PPB | 0.967429 |
| VDSS | 1.21 |
| FU | 0.0195919 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.349 |
| CYP2c19-inh | 0.053 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.052 |
| CYP2c9-sub | 0.938 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.103 |
| CYP3a4-inh | 0.159 |
| CYP3a4-sub | 0.039 |
| CL | 6.32 |
| T12 | 0.025 |
| hERG | 0.239 |
| Ames | 0.121 |
| ROA | 0.409 |
| SkinSen | 0.954 |
| Carcinogencity | 0.028 |
| EI | 0.01 |
| Respiratory | 0.839 |
| NR-Aromatase | 0.562 |
| Antiviral | Yes |
| Prediction | 0.619446 |